These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11484983)

  • 1. Serum cytokeratins determination in differentiated thyroid carcinoma.
    Appetecchia M; Meçule A; Ducci M; Palma L; Castelli M
    J Exp Clin Cancer Res; 2001 Jun; 20(2):253-6. PubMed ID: 11484983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ghrelin in human medullary thyroid carcinomas.
    Morpurgo PS; Cappiello V; Verga U; Vicentini L; Vaghi I; Lauri E; Nebuloni M; Beck-Peccoz P; Spada A
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):437-41. PubMed ID: 16181236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of cyclin D1 gene expression as a prognostic factor in benign and malignant thyroid lesions.
    Brzeziańska E; Cyniak-Magierska A; Sporny S; Pastuszak-Lewandoska D; Lewiński A
    Neuro Endocrinol Lett; 2007 Aug; 28(4):341-50. PubMed ID: 17693985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of cytokeratin 20 in thyroid carcinomas and peripheral blood detected by reverse transcription polymerase chain reaction.
    Weber T; Lacroix J; Weitz J; Amnan K; Magener A; Hölting T; Klar E; Herfarth C; von Knebel Doeberitz M
    Br J Cancer; 2000 Jan; 82(1):157-60. PubMed ID: 10638983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of serum PDN-21 (Katacalcin) levels by radioimmunoassay in patients with various thyroid diseases.
    Takami H
    Exp Clin Endocrinol; 1994; 102(5):370-3. PubMed ID: 7867699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. uPA receptor expression in benign and malignant thyroid tumors.
    Kim SJ; Shiba E; Taguchi T; Tsukamoto F; Miyoshi Y; Tanji Y; Takai S; Noguchi S
    Anticancer Res; 2002; 22(1A):387-93. PubMed ID: 12017319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum vascular endothelial growth factor C correlates with lymph node metastases and high-risk tumor profiles in papillary thyroid carcinoma.
    Yu XM; Lo CY; Lam AK; Leung P; Luk JM
    Ann Surg; 2008 Mar; 247(3):483-9. PubMed ID: 18376194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of estimation of the ratio of preoperative serum thyroglobulin to the thyroid mass in predicting the behaviour of well differentiated thyroid cancers.
    Sharma AK; Sarda AK; Chattopadhyay TK; Kapur MM
    J Postgrad Med; 1996; 42(2):39-42. PubMed ID: 9715297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreas cancer-associated antigen (PCAA) in medullary thyroid carcinoma.
    Ueno K; Kobayashi T; Shimano T; Matsuura N; Monden T; Takeda T; Tomita N; Mori T
    Med J Osaka Univ; 1994 Sep; 43(1-4):17-21. PubMed ID: 7609706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum calcitonin levels.
    Iacobone M; Niccoli-Sire P; Sebag F; De Micco C; Henry JF
    World J Surg; 2002 Aug; 26(8):886-90. PubMed ID: 12016469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncofoetal fibronectin--a tumour-specific marker in detecting minimal residual disease in differentiated thyroid carcinoma.
    Hesse E; Musholt PB; Potter E; Petrich T; Wehmeier M; von Wasielewski R; Lichtinghagen R; Musholt TJ
    Br J Cancer; 2005 Sep; 93(5):565-70. PubMed ID: 16091757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of angiogenic growth factors in patients with thyroid gland tumors and parathyroid adenoma.
    Veselý D; Astl J; Matucha P; Sterzl I; Betka J
    Neuro Endocrinol Lett; 2003 Dec; 24(6):417-9. PubMed ID: 15073567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiated thyroid carcinomas with vascular invasion: a comparative study of follicular, Hürthle cell and papillary thyroid carcinoma.
    Mai KT; Khanna P; Yazdi HM; Perkins DG; Veinot JP; Thomas J; Lamba M; Nair BD
    Pathology; 2002 Jun; 34(3):239-44. PubMed ID: 12109784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-molecular-weight cytokeratin and cytokeratin-19 in the diagnosis of thyroid tumors.
    Raphael SJ; McKeown-Eyssen G; Asa SL
    Mod Pathol; 1994 Apr; 7(3):295-300. PubMed ID: 7520169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expressions of CK-19, NF-kappaB, E-cadherin, beta-catenin and EGFR as diagnostic and prognostic markers by immunohistochemical analysis in thyroid carcinoma.
    Sethi K; Sarkar S; Das S; Rajput S; Mazumder A; Roy B; Patra S; Mohanty B; El-Naggar AK; Mandal M
    J Exp Ther Oncol; 2011; 9(3):187-99. PubMed ID: 22070050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
    Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
    Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of lymph node metastasis and distant metastasis of thyroid carcinoma.
    Machens A; Holzhausen HJ; Lautenschläger C; Thanh PN; Dralle H
    Cancer; 2003 Aug; 98(4):712-9. PubMed ID: 12910514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of primary tumor size in papillary and follicular thyroid carcinoma.
    Machens A; Holzhausen HJ; Dralle H
    Cancer; 2005 Jun; 103(11):2269-73. PubMed ID: 15856429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromogranin A: an additional tumor marker for postoperative recurrence and metastases of medullary thyroid carcinomas?
    Franke WG; Pinkert J; Runge R; Bredow J; Wunderlich G; Koch R
    Anticancer Res; 2000; 20(6D):5257-60. PubMed ID: 11326706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inverse correlation between heparan sulfate composition and heparanase-1 gene expression in thyroid papillary carcinomas: a potential role in tumor metastasis.
    Xu X; Quiros RM; Maxhimer JB; Jiang P; Marcinek R; Ain KB; Platt JL; Shen J; Gattuso P; Prinz RA
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5968-79. PubMed ID: 14676122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.